Marksans Pharma Receives US FDA Nod For Loratdine Drug

Marksans Pharma Receives US FDA Nod For Loratdine Drug

MARKSANA PHARMA: STELLAR RALLY. Receives USFDA Nod For Anti-Allergy DrugПодробнее

MARKSANA PHARMA: STELLAR RALLY. Receives USFDA Nod For Anti-Allergy Drug

Marksans Pharma Big Breakthrough: USFDA Approval Ka Asar | Stock Analysis | Multibagger | Hidden GemПодробнее

Marksans Pharma Big Breakthrough: USFDA Approval Ka Asar | Stock Analysis | Multibagger | Hidden Gem

Marksans Pharma’s Goa Plant Inspection By UK MHRA CompleteПодробнее

Marksans Pharma’s Goa Plant Inspection By UK MHRA Complete

Marksans Pharma Gains After USFDA Approval for Loratadine TabletsПодробнее

Marksans Pharma Gains After USFDA Approval for Loratadine Tablets

Marksans Pharma's Big Break: USFDA Nod for Allergy Drug! | Stock Analysis | Multibagger | Hidden GemПодробнее

Marksans Pharma's Big Break: USFDA Nod for Allergy Drug! | Stock Analysis | Multibagger | Hidden Gem

Sun Pharma Receives US FDA Nod For GlumetzaПодробнее

Sun Pharma Receives US FDA Nod For Glumetza

Cadila Receives US FDA Nod For Two DrugsПодробнее

Cadila Receives US FDA Nod For Two Drugs

USFDA: Pharma regulator is among world's most powerful bodiesПодробнее

USFDA: Pharma regulator is among world's most powerful bodies

FDA EXPANDS WARNING-CONTAMINATED DRUGS FROM NECCПодробнее

FDA EXPANDS WARNING-CONTAMINATED DRUGS FROM NECC

FDA allows pharmacists to prescribe pill to treat COVIDПодробнее

FDA allows pharmacists to prescribe pill to treat COVID

Novartis CEO: We're moving toward filing Covid drug from Molecular Partners with FDAПодробнее

Novartis CEO: We're moving toward filing Covid drug from Molecular Partners with FDA

Pharmaceutical Quality Symposium 2021 Part 5Подробнее

Pharmaceutical Quality Symposium 2021 Part 5

Breakthrough Allergy Medicine Not Approved By FDAПодробнее

Breakthrough Allergy Medicine Not Approved By FDA

Expert recommends 'Marksans Pharma' for investment in Today's tradeПодробнее

Expert recommends 'Marksans Pharma' for investment in Today's trade

Provenge Gets FDA ApprovalПодробнее

Provenge Gets FDA Approval

Sarah McMullen Of US FDA On Compliance Issues With Indian Pharma Companies | CNBC TV18Подробнее

Sarah McMullen Of US FDA On Compliance Issues With Indian Pharma Companies | CNBC TV18

Standouts from the 2024 FDA Drug Approvals: Xanomeline-Trospium Combo, Sotatercept, GivinostatПодробнее

Standouts from the 2024 FDA Drug Approvals: Xanomeline-Trospium Combo, Sotatercept, Givinostat

Pharma Industry News @07 June 2019 | PharmaStateПодробнее

Pharma Industry News @07 June 2019 | PharmaState

Pharma Stocks Remain In Focus TodayПодробнее

Pharma Stocks Remain In Focus Today